These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29241444)

  • 1. Willingness to pay for flexible working conditions of people with type 2 diabetes: discrete choice experiments.
    Nexo MA; Cleal B; Hagelund L; Willaing I; Olesen K
    BMC Public Health; 2017 Dec; 17(1):938. PubMed ID: 29241444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for flexibility at the workplace for people with diabetes and chronic disease: a discrete choice experiment in a population of workers in Denmark.
    Madsen KP; Cleal B; Olesen K; Hagelund L; Willaing I
    BMC Public Health; 2019 May; 19(1):584. PubMed ID: 31096952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for improved working conditions of nurses: Results from a factorial survey experiment in Germany.
    Wolff R; Heusler A; Kunaschk M; Osiander C
    Int J Nurs Stud; 2024 Jul; 155():104779. PubMed ID: 38744074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2].
    Moro D; Schlander M; Telser H; Sola-Morales O; Clark MD; Olaye A; Camp C; Jain M; Butt T; Bakshi S
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):581-598. PubMed ID: 34877915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A; Nafees B; Barnett AH; Heller S; Ploug UJ; Lammert M; Bøgelund M
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness-to-Pay for Community-Based Health Insurance among Informal Workers in Urban Bangladesh.
    Ahmed S; Hoque ME; Sarker AR; Sultana M; Islam Z; Gazi R; Khan JA
    PLoS One; 2016; 11(2):e0148211. PubMed ID: 26828935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
    Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to accept versus willingness to pay in a discrete choice experiment.
    Grutters JP; Kessels AG; Dirksen CD; van Helvoort-Postulart D; Anteunis LJ; Joore MA
    Value Health; 2008 Dec; 11(7):1110-9. PubMed ID: 18489505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
    Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the validity of the payment card and structured haggling willingness to pay methods: The case of a diabetes prevention program in rural Kenya.
    Kangethe A; Franic DM; Corso PS
    Soc Sci Med; 2016 Nov; 169():86-96. PubMed ID: 27701019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A valuation of patients' willingness-to-pay for insulin delivery in diabetes.
    Guimarães C; Marra CA; Colley L; Gill S; Simpson SH; Meneilly GS; Queiroz RH; Lynd LD
    Int J Technol Assess Health Care; 2009 Jul; 25(3):359-66. PubMed ID: 19619355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results.
    Jendle J; Torffvit O; Ridderstråle M; Ericsson Å; Nilsen B; Bøgelund M
    J Med Econ; 2012; 15 Suppl 2():1-5. PubMed ID: 22853443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing a Lifestyle Intervention for Middle Eastern Immigrants at Risk of Diabetes.
    Saha S; Gerdtham UG; Siddiqui F; Bennet L
    Int J Environ Res Public Health; 2018 Feb; 15(3):. PubMed ID: 29495529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician and patient willingness to pay for electronic cardiovascular disease management.
    Deal K; Keshavjee K; Troyan S; Kyba R; Holbrook AM
    Int J Med Inform; 2014 Jul; 83(7):517-28. PubMed ID: 24862891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment.
    Aristides M; Weston AR; FitzGerald P; Le Reun C; Maniadakis N
    Value Health; 2004; 7(4):442-54. PubMed ID: 15449636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.